GGrantIndex
← Search

Structural Biology Shared Resource

$107,355P30FY2024CANIH

Albert Einstein College Of Medicine, Bronx NY

Investigators

Linked publications, trials & patents

Paper 39499645Paper 39392861Paper 39378878Paper 39332920Paper 39259591Paper 39207105Paper 39193906Paper 39127153Paper 39081315Paper 39028768Paper 39025270Paper 38902475Paper 38898085Paper 38896451Paper 38863869Paper 38778498Paper 38753503Paper 38717519Paper 38700353Paper 38699331Paper 38679747Paper 38657656Paper 38645169Paper 38643166Paper 38608634Paper 38597673Paper 38571760Paper 38565851Paper 38559037Paper 38477945Paper 38463959Paper 38458178Paper 38436133Paper 38405931Paper 38402617Paper 38400039Paper 38387080Paper 38352476Paper 38334805Trial NCT05016622Trial NCT04514484Trial NCT04401670Trial NCT03648983Trial NCT02774291Trial NCT02649569Trial NCT02578888Trial NCT02575872Trial NCT02527304Trial NCT02507076Trial NCT02382419Trial NCT02277561Trial NCT02112552Trial NCT02073968Trial NCT02038153Trial NCT02009436Trial NCT01958580Trial NCT01939210Trial NCT01899326Trial NCT01899261Trial NCT01897454Trial NCT01897441Trial NCT01857271Trial NCT01772420Trial NCT01697293Trial NCT01695941Trial NCT01605032Trial NCT01408160Trial NCT01367301Trial NCT01351909Trial NCT01319539Trial NCT01231906Trial NCT01145430Trial NCT01142401Trial NCT01061606Trial NCT01041027Trial NCT01001910Trial NCT00950365Trial NCT00470301Trial NCT00450944Trial NCT00437034Trial NCT00392353Trial NCT00324740Trial NCT00182767Trial NCT00179348Trial NCT00121251Trial NCT00096317Trial NCT00066638Trial NCT00057863Trial NCT00055692Trial NCT00030706Trial NCT00019474Trial NCT00004864Trial NCT00004863Trial NCT00003867Trial NCT00002461Patent 9671391Patent 7709613Patent 6821725Patent 6013468Patent 5876979

Abstract

Program Director/Principal Investigator (Last, First, Middle): Chu, Edward STRUCTURAL BIOLOGY SHARED RESOURCE - PROJECT SUMMARY/ABSTRACT The Structural Biology Shared Resource (SBSR) supports a wide range of technologies for identifying new targets, defining molecular mechanisms, and generating tool compounds and therapeutic leads. Services include: 1) state-of-the-art protein production; 2) high resolution structure determination by X-ray crystallography, NMR and cryo-EM; 3) mass spectrometry-based proteomics analyses; and 4) additional advanced technologies. SBSR provides access to state-of-the-art infrastructure located in-house and at regional centers and national laboratories to support the scientific priorities outlined in the MECC Strategic Plan. Protein-based tools facilitate the mechanistic dissection of fundamental biological and pathological processes, and the validation of potential therapeutic strategies in cell- and animal-based disease models. Mass spectrometry and proteomics enables the discovery of new targets and biomarkers, and provides deep mechanistic insight into responses associated with disease states and treatment regimens. Structural data provide atomic-resolution insight for protein design and medicinal chemistry essential for enhancing initial hits and lead therapeutics. The SBSR Specific Aims are: Aim 1: Provide state-of-the-art technologies for protein expression, purification and characterization, and validation. These resources include bacterial, insect cell, and mammalian cell expression platforms supported by considerable automation to facilitate these efforts. SBSR staff provide the full range of support services, including construct design and downstream characterization. Aim 2: Enable high resolution structural characterization. Available resources include in-house capabilities in NMR, X-ray crystallography and cryo-EM, as well as extensive access to state-of-the art national facilities for NMR and cryo-EM (New York Structural Biology Center) and X-ray crystallography (Brookhaven National Laboratory and Argonne National Laboratory). SBSR staff provide the full range of support services, including data collection and processing, structure determination, validation, and structure interpretation. Aim 3: Provide state-of-the-art mass spectrometry capabilities for proteomics analyses, including protein abundance, determination of regulated protein pathways and other networks, identification and quantification of protein post-translational modifications and protein synthesis rates. SBSR staff provide the full range of support services, spanning experimental design, sample preparation, data acquisition and data interpretation. The breadth of core services supports the entire spectrum of investigators, and the extensive coordination among the SBSR leaders allows for the seamless movement among core-supported technologies. As such, projects can enter the pipeline at any stage. For example, inexperienced investigators can enter the pipeline at the protein expression stage and receive support all the way through structure determination and interpretation. OMB No. 0925-0001/0002 (Rev. 03/2020 Approved Through 02/28/2023) Page

View original record on NIH RePORTER →